Curcumin mediates presenilin-1 activity to reduce β-amyloid production in a model of Alzheimer's disease

Pharmacological Reports

Volumn 63, Issue 5, 2011, Pages 1101-1108

  Zhang, Xiong ^a   Zhang, Hongmei ^a   Si, Lu ^a   Li, Yu ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Curcumin; GSK 3 ; PS1; amyloid

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; CURCUMIN; GAMMA SECRETASE; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; PRESENILIN 1;

ALZHEIMER DISEASE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3BETA GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROBLASTOMA CELL; PRESENILIN 1 GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 83155181938     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/s1734-1140(11)70629-6     Document Type: Article

References (22)

1. Chandra V, Pandav R, Dodge HH, Johnston JM, Belle SH, De Kosky ST, Ganguli M: Incidence of Alzheimer's disease in a rural community in India: the Indo-US study. Neurology, 2001, 57, 985-989. (Pubitemid 32880190)
2. Di Santo R, Costi R, Artico M, Ragno R, Greco G, Novellino E, Marchand C, Pommier Y: Design, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids as HIV-1 integrase inhibitors endowed with antiretroviral activity. Farmaco, 2005, 60, 409-417. (Pubitemid 40731526)
3. Embi N, Rylatt DB and Cohen P: Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem, 1980, 107, 519-527.
4. Folwarczna J, Zych M, Trzeciak HI: Effects of curcumin on the skeletal system in rats. Pharmacol Rep, 2010, 62, 900-909.
5. Giliberto L, Borghi R, Piccini A, Mangerini R, Sorbi S, Cirmena G, Garuti A et al.: Mutant presenilin 1 increases the expression and the activity of bace1. J Biol Chem, 2009, 284, 9027-9038.
6. Glenner, GG, Wong CW: Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun, 1984, 120, 885-890. (Pubitemid 14104991)
7. Hua WF, Fu YS, Liao YJ, Xia WJ, Chen YC, Zeng YX, Kung HF, Xie D: Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells. Eur J Pharmacol, 2010, 637, 16-21.
8. Koosirirat C, Linpisarn S, Changsom D, Chawansuntati K, Wipasa J: Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients. Int Immunopharmacol, 2010, 10, 815-818.
9. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingel WH, Yu CE et al.: Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science, 1995, 269, 973-977.
10. Li YM, Xu M, Lai MT, Huang Q, Castro JL, DiMuzio- Mower J, Harrison T et al.: Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1. Nature, 2000, 405, 689-694. (Pubitemid 30428655)
11. Serneels L, Van Biervliet J, Craessaerts K, Dejaegere T, Horre K, Van Houtvin T, Esselmann T et al.: γ-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer's disease. Science, 2009, 324, 639-642.
12. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesgue G, Ikeda M, Chi H et al.: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature, 1995, 375, 754-760.
13. Sun X, Wang Y, Qing H, Christensen MA, Liu Y, Zhou W, Tong Y et al.: Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes. FASEB J, 2005, 19, 739-749. (Pubitemid 40617378)
14. Tesco G, Tanzi RE: GSK-3β forms a tetrameric complex with endogenous PS1-CTF/NTF and β-catenin. Ann NY Acad Sci, 2000, 920, 227-232.
15. Twomey C, McCarthy JV: Presenilin-1 is an unprimed glycogen synthase kinase-3β substrate. FEBS Lett, 2006, 580, 4015-4020. (Pubitemid 44037562)
16. Vassar R: β-Secretase, APP and Aβ in Alzheimer's disease. Subcell Biochem, 2005, 38, 79-103.
17. Wang HM, Zhao YX, Zhang S, Liu GD, Kang WY, Tang HD, Ding JQ, Chen SD: PPAR-γ agonist curcumin reduces the amyloid-β-stimulated inflammatory responses in primary astrocytes. J Alzheimers Dis, 2010, 20, 1189-1199.
18. Wehrli M, Dougan ST, Caldwell K, O'Keefe L, Schwartz S, Vaizel-Ohayon D, Schejter E et al.: Arrow encodes an LDL-receptor-related protein essential for Wingless signaling. Nature, 2000, 407, 527-530.
19. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ: Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature, 1999, 398, 513-517.
20. Woodgett, JR and Cohen P: Multisite phosphorylation of glycogen synthase. Molecular basis for the substrate specificity of glycogen synthase kinase-3 and casein kinase-II (glycogen synthase kinase-5). Biochim Biophys Acta, 1984, 788, 339-347. (Pubitemid 14031544)
21. Zhan J, Sun X, Yu Z, Pan X, Gu F, Chen J, Dong Wet al: Exposure to pyrithiamine increases β-amyloid accumulation, Tau hyperphosphorylation, and glycogen synthase kinase-3 activity in the brain. Neurotox Res, 2011, 19, 575-583.
22. Zhang C, Browne A, Child D, Tanzi RE: Curcumin decreases amyloid-β peptide levels by attenuating the maturation of amyloid-β precursor protein. J Biol Chem, 2010, 285, 28472-28480.